Our research focuses on studying gut microbial populations concerning human intestinal diseases, such as Crohn's disease and colorectal cancer, and metabolic disorders. Our research aims to contribute to an improvement of the diagnostic and prognostic methods for these diseases, based on the identification of microbial biomarkers, and to uncover bacterial mechanisms of pathogenicity that could be a target for future treatments